These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital]. Arimura E; Nakamuta M; Kotoh K; Morizono S; Fukutomi M; Ohta S; Enjoji M; Sakai H; Nawata H Fukuoka Igaku Zasshi; 2004 Aug; 95(8):195-200. PubMed ID: 15552961 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic role of pan-Ras, Raf-1, pMEK1 and pERK1/2 in patients with hepatocellular carcinoma. Chen L; Shi Y; Jiang CY; Wei LX; Wang YL; Dai GH Eur J Surg Oncol; 2011 Jun; 37(6):513-20. PubMed ID: 21324414 [TBL] [Abstract][Full Text] [Related]
11. Molecular markers and hepatocellular carcinoma: lending a helping hand in liver transplantation? Dai Z; Yu L; Zhou J; Qiu SJ; Fan J Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):211-3. PubMed ID: 19485802 [No Abstract] [Full Text] [Related]
12. Hepatocellular carcinoma in 2011 and beyond: from the pathogenesis to molecular targeted therapy. Kudo M Oncology; 2011; 81 Suppl 1():1-10. PubMed ID: 22212929 [TBL] [Abstract][Full Text] [Related]
13. Chemoembolization and bland embolization: a critical appraisal. Befeler AS Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274 [TBL] [Abstract][Full Text] [Related]
14. [The role of tumor markers in the diagnosis and follow-up of liver tumors]. Ottó S Orv Hetil; 2004 Feb; 145(7 Suppl 1):385-7. PubMed ID: 15049057 [TBL] [Abstract][Full Text] [Related]
16. [Primary liver tumors in children]. Vos A; Kuijper CF Ned Tijdschr Geneeskd; 1995 Sep; 139(38):1918-22. PubMed ID: 7477530 [No Abstract] [Full Text] [Related]
17. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Stuart KE; Anand AJ; Jenkins RL Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087 [TBL] [Abstract][Full Text] [Related]
18. Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma. Liang XT; Pan K; Chen MS; Li JJ; Wang H; Zhao JJ; Sun JC; Chen YB; Ma HQ; Wang QJ; Xia JC J Gastroenterol Hepatol; 2011 Mar; 26(3):544-9. PubMed ID: 21332550 [TBL] [Abstract][Full Text] [Related]